Pricing Log in Create free account
Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

60.89 2.83 +4.87%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bruker Corporation 10-Q filed Nov 5, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 4:02 PM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    Bruker Corporation recorded a goodwill impairment of $174.5 million in fiscal Q3 2026

    10-Q filed · The filing · sec.gov

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 5, 2026: 18 added · 12 removed · 31 modified; 4 with only figures updated

  1. Modified

    our ability to identify suitable acquisition targets and successfully integrate and manage acquired businessbusinesses; and